Premium Intraocular Lenses/IOL
Search documents
Bausch + Lomb (BLCO) Reports Record Q4 2025 Financial Results Driven by Strong Pharmaceutical and Vision Care Growth
Yahoo Finance· 2026-02-27 10:14
Bausch + Lomb Corporation (NYSE:BLCO) is one of the best Canadian stocks to buy under $20. On February 18, Bausch + Lomb reported record financial results for Q4 2025, with revenue rising 7% to $1.405 billion and adjusted EBITDA growing 27% to $330 million. This brought full-year revenue to $5.101 billion, driven by strong gains across its diversified portfolio. The company’s pharmaceutical segment led the way with 14% quarterly growth, while the Vision Care division, led by an 8% increase in contact lens ...